The Ocular Phenotype in Primary Hyperoxaluria Type 1
Johannes Birtel(Universität Hamburg), Peter Charbel Issa(Technical University of Munich), Frank G. Holz(Universitäts-Augenklinik Bonn), Yevgeniya Atiskova(Universität Hamburg), Roselie M.H. Diederen(Amsterdam University Medical Centers), Florian Brinkert(Universität Hamburg), Bernd Höppe(University of Bonn), Sander F. Garrelfs(Emma Kinderziekenhuis), Philipp Herrmann(University of Bonn), Simon Dulz(Universität Hamburg), Camiel J. F. Boon(Amsterdam University Medical Centers), Martin Gliem(Roche (Switzerland))
Cited by 30
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
The primary hyperoxalurias
|Kidney International|2009|373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361